Chembio Diagnostics Inc (CEMI)

8.45
NASDAQ : Health Care
Prev Close 8.34
Day Low/High 8.38 / 8.48
52 Wk Low/High 3.33 / 9.40
Avg Volume 41.40K
Exchange NASDAQ
Shares Outstanding 9.67M
Market Cap 80.65M
EPS -0.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Chembio To Host Conference Call To Discuss First Quarter 2016 Financial Results

Chembio To Host Conference Call To Discuss First Quarter 2016 Financial Results

Conference Call Scheduled for Thursday, May 12th At 10:00 a.m. Eastern Time

Chembio Diagnostics Reports 2015 Financial Results

Chembio Diagnostics Reports 2015 Financial Results

Conference Call and Webcast Today at 10:00 a.m. Eastern Time

Chembio To Host Conference Call To Discuss 2015 Financial Results

Chembio To Host Conference Call To Discuss 2015 Financial Results

Conference Call Scheduled for Tuesday, March 8th at 10:00a.m. Eastern Time

Chembio To Sell Its SURE CHECK® HIV 1/2 Assay In The United States Beginning June 1, 2016

Chembio To Sell Its SURE CHECK® HIV 1/2 Assay In The United States Beginning June 1, 2016

Exclusive U.S. Distribution Agreement With Alere to Terminate May 31, 2016

Chembio Diagnostics Reports Third Quarter Financial Results

Chembio Diagnostics Reports Third Quarter Financial Results

Conference Call and Webcast Today at 10:00 a.m. Eastern Time

Chembio To Host Conference Call To Discuss Third Quarter 2015 Financial Results

Chembio To Host Conference Call To Discuss Third Quarter 2015 Financial Results

Conference Call Scheduled for Thursday, November 12th at 10:00 a.m. Eastern Time

Chembio Diagnostics Reports Second Quarter Financial Results

Chembio Diagnostics Reports Second Quarter Financial Results

Conference Call and Webcast Today at 10:00 a.m. Eastern Time

Chembio To Host Conference Call To Discuss Second Quarter 2015 Financial Results

Chembio To Host Conference Call To Discuss Second Quarter 2015 Financial Results

Conference Call Scheduled for Thursday, August 6th at 10:00a.m. Eastern Time

Chembio's DPP(R) HIV 1/2 Assay Receives CE Mark Approval For Rapid Point-of-Care Detection Of HIV

Chembio's DPP(R) HIV 1/2 Assay Receives CE Mark Approval For Rapid Point-of-Care Detection Of HIV

Sales of DPP(R) HIV 1/2 Assay in Europe Anticipated in Q4 2015

Chembio Diagnostics Reports First Quarter 2015 Financial Results

Chembio Diagnostics Reports First Quarter 2015 Financial Results

Conference Call and Webcast Today at 10:00 a.m. Eastern Time

Chembio To Host Conference Call To Discuss First Quarter 2015 Financial Results

Chembio To Host Conference Call To Discuss First Quarter 2015 Financial Results

Conference Call Scheduled for Thursday, May 7th at 10:00a.m. Eastern Time

Chembio Diagnostics Reports 2014 Financial Results

Chembio Diagnostics Reports 2014 Financial Results

Conference Call and Webcast Today at 10:00 a.m. Eastern

Chembio To Host Conference Call To Discuss 2014 Financial Results

Chembio To Host Conference Call To Discuss 2014 Financial Results

Conference Call Scheduled for Thursday, March 5th at 10:00a.m. Eastern Time

Chembio's DPP(R) HIV-Syphilis Assay Cleared For Launch In Brazil

Chembio's DPP(R) HIV-Syphilis Assay Cleared For Launch In Brazil

Only Combination Assay Approved by Brazil's ANVISA for Point-of-Care Detection of HIV and Syphilis

Chembio Awarded Grant To Develop Next-Generation Point-of-Care Diagnostic Test For Malaria

Chembio Awarded Grant To Develop Next-Generation Point-of-Care Diagnostic Test For Malaria

Chembio to Support the Bill & Melinda Gates Foundation Malaria Eradication Campaign